• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ICOS-ICOSL 通路调节胸腺选择。

The ICOS-ICOSL pathway tunes thymic selection.

机构信息

Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC, Canada.

Immunology-Oncology Unit, Maisonneuve-Rosemont Hospital Research Center, Montréal, QC, Canada.

出版信息

Immunol Cell Biol. 2022 Mar;100(3):205-217. doi: 10.1111/imcb.12520. Epub 2022 Jan 23.

DOI:10.1111/imcb.12520
PMID:34962663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9304562/
Abstract

Negative selection of developing T cells plays a significant role in T-cell tolerance to self-antigen. This process relies on thymic antigen-presenting cells which express both self-antigens and cosignaling molecules. Inducible T-cell costimulator (ICOS) belongs to the CD28 family of cosignaling molecules and binds to ICOS ligand (ICOSL). The ICOS signaling pathway plays important roles in shaping the immune response to infections, but its role in central tolerance is less well understood. Here we show that ICOSL is expressed by subsets of thymic dendritic cells and medullary thymic epithelial cells as well as thymic B cells. ICOS expression is upregulated as T cells mature in the thymus and correlates with T-cell receptor signal strength during thymic selection. We also provide evidence of a role for ICOS signaling in mediating negative selection. Our findings suggest that ICOS may fine-tune T-cell receptor signals during thymic selection contributing to the generation of a tolerant T-cell population.

摘要

负选择在 T 细胞发育过程中发挥着重要作用,可使 T 细胞对自身抗原产生耐受。这一过程依赖于表达自身抗原和共刺激分子的胸腺抗原呈递细胞。诱导性 T 细胞共刺激分子(ICOS)属于 CD28 家族的共刺激分子,与 ICOS 配体(ICOSL)结合。ICOS 信号通路在调节对感染的免疫反应中起着重要作用,但它在中枢耐受中的作用还不太清楚。在这里,我们发现 ICOSL 在胸腺树突状细胞和髓质胸腺上皮细胞以及胸腺 B 细胞亚群中表达。ICOS 的表达随着 T 细胞在胸腺中的成熟而上调,并与胸腺选择过程中 T 细胞受体信号强度相关。我们还提供了证据表明 ICOS 信号在介导阴性选择中发挥作用。我们的研究结果表明,ICOS 可能在胸腺选择过程中微调 T 细胞受体信号,有助于产生耐受的 T 细胞群体。

相似文献

1
The ICOS-ICOSL pathway tunes thymic selection.ICOS-ICOSL 通路调节胸腺选择。
Immunol Cell Biol. 2022 Mar;100(3):205-217. doi: 10.1111/imcb.12520. Epub 2022 Jan 23.
2
Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses.通过与诱导共刺激分子(ICOS)相互作用而下调ICOS配体,作为免疫反应的一种调节机制发挥作用。
J Immunol. 2008 Apr 15;180(8):5222-34. doi: 10.4049/jimmunol.180.8.5222.
3
Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production.诱导共刺激分子(ICOS)及其配体信号通过细胞因子的产生在皮肤伤口愈合中发挥关键作用。
Am J Pathol. 2011 Nov;179(5):2360-9. doi: 10.1016/j.ajpath.2011.07.048. Epub 2011 Sep 15.
4
CTLA4-Ig-Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function.基于 CTLA4-Ig 的双功能共刺激抑制剂阻断 CD28 和 ICOS 信号传导,以防止 T 细胞启动和效应功能。
J Immunol. 2021 Mar 1;206(5):1102-1113. doi: 10.4049/jimmunol.2001100. Epub 2021 Jan 25.
5
Characterization of human inducible costimulator ligand expression and function.人诱导共刺激配体的表达及功能特性
J Immunol. 2000 May 1;164(9):4689-96. doi: 10.4049/jimmunol.164.9.4689.
6
Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.深度流式细胞术揭示实验性自身免疫性脑脊髓炎期间诱导性T细胞共刺激配体(ICOSL)和ICOS基因敲除小鼠中不同的免疫细胞亚群。
Int J Mol Sci. 2024 Feb 21;25(5):2509. doi: 10.3390/ijms25052509.
7
Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway.可诱导共刺激配体在小鼠模型中独立于可诱导共刺激分子/可诱导共刺激配体途径调节博来霉素诱导的肺和皮肤纤维化。
Arthritis Rheum. 2010 Jun;62(6):1723-32. doi: 10.1002/art.27428.
8
Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis.早期弥漫性皮肤系统性硬化症患者的 ICOS 表达增强。
Rheumatology (Oxford). 2013 Feb;52(2):242-51. doi: 10.1093/rheumatology/kes258. Epub 2012 Sep 29.
9
Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.急性髓系白血病细胞表达 ICOSL 配体促进调节性 T 细胞的扩增。
Front Immunol. 2018 Sep 26;9:2227. doi: 10.3389/fimmu.2018.02227. eCollection 2018.
10
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.诱导性T细胞共刺激分子(ICOS)及其配体是多发性骨髓瘤微环境中的新成员。
Br J Haematol. 2022 Mar;196(6):1369-1380. doi: 10.1111/bjh.17968. Epub 2021 Dec 26.

引用本文的文献

1
Mechanisms and clinical translation of ICOS/ICOSL signaling pathway blockade in delaying vascular complications of type 2 diabetes.ICOS/ICOSL信号通路阻断在延缓2型糖尿病血管并发症中的机制及临床转化
Diabetol Metab Syndr. 2025 Aug 13;17(1):328. doi: 10.1186/s13098-025-01891-6.
2
Spatial mapping of innate lymphoid cells in human lymphoid tissues and lymphoma at single-cell resolution.以单细胞分辨率对人类淋巴组织和淋巴瘤中的固有淋巴细胞进行空间映射。
Nat Commun. 2025 May 15;16(1):4545. doi: 10.1038/s41467-025-59811-1.
3
Current state of cancer immunity cycle: new strategies and challenges of using precision hydrogels to treat breast cancer.

本文引用的文献

1
Differential expression of tissue-restricted antigens among mTEC is associated with distinct autoreactive T cell fates.组织限制性抗原在 mTEC 中的差异表达与不同的自身反应性 T 细胞命运有关。
Nat Commun. 2020 Jul 24;11(1):3734. doi: 10.1038/s41467-020-17544-3.
2
Testing the Efficiency and Kinetics of Negative Selection Using Thymic Slices.使用胸腺切片检测阴性选择的效率和动力学。
Methods Mol Biol. 2020;2111:205-219. doi: 10.1007/978-1-0716-0266-9_17.
3
IL-2 production by self-reactive CD4 thymocytes scales regulatory T cell generation in the thymus.
癌症免疫循环的现状:使用精准水凝胶治疗乳腺癌的新策略与挑战
Front Immunol. 2025 Mar 7;16:1535464. doi: 10.3389/fimmu.2025.1535464. eCollection 2025.
4
Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma Microenvironment.补体因子H是一种调节胶质瘤微环境中调节性T细胞的ICOS配体。
Cancer Immunol Res. 2025 Jan 9;13(1):122-138. doi: 10.1158/2326-6066.CIR-23-1092.
5
Stabilization of β-Catenin Directs HEB to Limit Thymic Selection.β-连环蛋白的稳定作用将 HEB 导向限制胸腺选择。
J Immunol. 2024 Sep 1;213(5):641-650. doi: 10.4049/jimmunol.2400160.
6
Deciphering the developmental trajectory of tissue-resident Foxp3 regulatory T cells.解析组织驻留 Foxp3 调节性 T 细胞的发育轨迹。
Front Immunol. 2024 Mar 28;15:1331846. doi: 10.3389/fimmu.2024.1331846. eCollection 2024.
自身反应性 CD4 胸腺细胞产生的白细胞介素 2 调节了胸腺中调节性 T 细胞的生成。
J Exp Med. 2019 Nov 4;216(11):2466-2478. doi: 10.1084/jem.20190993. Epub 2019 Aug 21.
4
Inducible T-cell co-stimulator: Signaling mechanisms in T follicular helper cells and beyond.可诱导共刺激分子:滤泡辅助性 T 细胞中的信号机制及其他作用。
Immunol Rev. 2019 Sep;291(1):91-103. doi: 10.1111/imr.12771.
5
Thymic regulatory T cells arise via two distinct developmental programs.胸腺调节性 T 细胞通过两个不同的发育程序产生。
Nat Immunol. 2019 Feb;20(2):195-205. doi: 10.1038/s41590-018-0289-6. Epub 2019 Jan 14.
6
Cutting Edge: ICOS-Deficient Regulatory T Cells Display Normal Induction of but Readily Downregulate Expression of Foxp3.前沿:ICOS 缺陷的调节性 T 细胞显示正常的诱导,但容易下调 Foxp3 的表达。
J Immunol. 2019 Feb 15;202(4):1039-1044. doi: 10.4049/jimmunol.1801266. Epub 2019 Jan 14.
7
Central CD4 T cell tolerance: deletion versus regulatory T cell differentiation.中央 CD4 T 细胞耐受:删除与调节性 T 细胞分化。
Nat Rev Immunol. 2019 Jan;19(1):7-18. doi: 10.1038/s41577-018-0083-6.
8
Single-cell RNA-sequencing resolves self-antigen expression during mTEC development.单细胞 RNA 测序解析 mTEC 发育过程中自身抗原的表达。
Sci Rep. 2018 Jan 12;8(1):685. doi: 10.1038/s41598-017-19100-4.
9
Directing T cell fate: How thymic antigen presenting cells coordinate thymocyte selection.指导 T 细胞命运:胸腺抗原呈递细胞如何协调胸腺细胞选择。
Semin Cell Dev Biol. 2018 Dec;84:2-10. doi: 10.1016/j.semcdb.2017.07.045. Epub 2017 Aug 9.
10
Preparation and Applications of Organotypic Thymic Slice Cultures.器官型胸腺切片培养物的制备与应用
J Vis Exp. 2016 Aug 6(114):54355. doi: 10.3791/54355.